Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5151-5155

  Lorenzo Morales, Jacob ^a,b   Martín Navarro, Carmen M ^a   López Arencibia, Atteneri ^a   Santana Morales, María A ^a   Afonso Lehmann, Raquel N ^a   Maciver, Sutherland K ^b   Valladares, Basilio ^a   Martínez Carretero, Enrique ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GLYCOGEN PHOSPHORYLASE; GLYCOGEN PHOSPHORYLASE INHIBITOR; LACTATE DEHYDROGENASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; DRUG SPECIFICITY; ENZYME RELEASE; GENE SILENCING; HUMAN; HUMAN CELL; MICROBIAL GROWTH; NONHUMAN; PRIORITY JOURNAL;

ACANTHAMOEBA; AMEBIASIS; ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; GENE SILENCING; HELA CELLS; HUMANS; MICE; RNA, SMALL INTERFERING;

EID: 78649662648     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00329-10     Document Type: Article

References (20)

1. Alsam, S., K. S. Kim, M. Stins, A. O. Rivas, J. Sissons, and N. A. Khan. 2003. Acanthamoeba interactions with human brain microvascular endothelial cells. Microb. Pathog. 35:235-241.
2. Clarke, D. W., and Y. Niederkorn. 2006. The pathophysiology of Acanthamoeba keratitis. Trends. Parasitol. 22:175-180.
3. Dart, J. K., V. P. Saw, and S. Kilvington. 2009. Acanthamoeba keratitis: diagnosis and treatment update. Am. J. Ophthalmol. 148:487-499.
4. Dudley, R., S. Alsam, and N. A. Khan. 2008. The role of proteases in the differentiation of Acanthamoeba castellanii. FEMS Microbiol. Lett. 286:9-15.
5. Khan, N. A., E. L. Jarroll, N. Panjwani, Z. Cao, and T. A. Paget. 2000. Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J. Clin. Microbiol. 38:2858-2861.
6. Khan, N. A. 2003. Pathogenesis of Acanthamoeba infections. Microb. Pathog. 34:277-285.
7. Khan, N. A. 2006. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol. Rev. 30:564-595.
8. Lackner, P., R. Beer, G. Broessner, R. Helbok, B. Pfausler, C. Brenneis, H. Auer, J. Walochnik, and E. Schmutzhard. 2010. Acute granulomatous Acanthamoeba encephalitis in an immunocompetent patient. Neurocrit. Care 12:91-94.
9. Lorenzo-Morales, J., A. Ortega-Rivas, P. Foronda, N. Abreu-Acosta, D. Ballart, E. Martínez, and B. Valladares. 2005. RNA interference (RNAi) for the silencing of extracellular serine proteases genes in Acanthamoeba: molecular analysis and effect on pathogenicity. Mol. Biochem. Parasitol. 144:10-16.
10. Lorenzo-Morales, J., J. Kliescikova, E. Martinez-Carretero, L. M. De Pablos, B. Profotova, E. Nohynkova, A. Osuna, and B. Valladares. 2008. Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference. Eukaryot. Cell 7:509-517.
11. Marciano-Cabral, F., and G. Cabral. 2003. Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16:273-307.
12. Martín-Navarro, C. M., J. Lorenzo-Morales, M. G. Cabrera-Serra, F. Rancel, N. M. Coronado-Álvarez, J. E. Piñero, and B. Valladares. 2008. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain. J. Med. Microbiol. 57:1399-1404.
13. Moon, E. K., D. I. Chung, Y. C. Hong, and H. H. Kong. 2009. Autophagy protein 8 mediating autophagosome in encysting Acanthamoeba. Mol. Biochem. Parasitol. 168:43-48.
14. Moon, E. K., D. I. Chung, Y. C. Hong, and H. H. Kong. 2008. Characterization of a serine proteinase mediating encystation of Acanthamoeba. Eukaryot. Cell 7:1513-1517.
15. Pederson, T. 2004. RNA interference and mRNA silencing, 2004: how far will they reach? Mol. Biol. Cell 15:407-410.
16. Schuster, F. L., and G. S. Visvesvara. 2004. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int. J. Parasitol. 34:1001-1027.
17. Schuster, F. L., and G. S. Visvesvara. 2004. Opportunistic amoebae: challenges in prophylaxis and treatment. Drug Resist. Updat. 7:41-51.
18. Shrey, K., A. Suchit, M. Nishant, and R. Vibha. 2009. RNA interference: emerging diagnostics and therapeutics tool. Biochem. Biophys. Res. Commun. 386:273-277.
19. Singhal, T., A. Bajpai, V. Kalra, S. K. Kabra, J. C. Samantaray, G. Satpathy, and A. K. Gupta. 2001. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr. Infect. Dis. J. 20:623-627.
20. Ullu, E., C. Tschudi, and T. Chakraborty. 2004. RNA interference in protozoan parasites. Cell. Microbiol. 6:509-519.